相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Vitamin K antagonists vs. direct oral anticoagulants after transcatheter aortic valve implantation in atrial fibrillation
Jawad H. Butt et al.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY (2021)
Meta-analysis of Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Bioprosthetic Valves
Babikir Kheiri et al.
AMERICAN JOURNAL OF CARDIOLOGY (2021)
Comparison of Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation and Heart Valves
Lewei Duan et al.
AMERICAN JOURNAL OF CARDIOLOGY (2021)
2020 ACC/AHA guideline for the management of patients with valvular heart disease
Catherine M. Otto et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2021)
Rivaroxaban in Patients with Atrial Fibrillation and a Bioprosthetic Mitral Valve
Helio P. Guimaraes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Variations in Anticoagulation Practice Following Bioprosthetic Aortic and Mitral Valve Replacement and Repair
Makoto Mori et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Direct Oral Anticoagulants Versus Vitamin K Antagonists in Patients With Atrial Fibrillation After TAVR
Hideyuki Kawashima et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2020)
Efficacy and safety of apixaban vs warfarin in patients with atrial fibrillation and prior bioprosthetic valve replacement or valve repair: Insights from the ARISTOTLE trial
Patricia O. Guimaraes et al.
CLINICAL CARDIOLOGY (2019)
Clinical Benefit of Direct Oral Anticoagulants Versus Vitamin K Antagonists in Patients with Atrial Fibrillation and Bioprosthetic Heart Valves
Vincenzo Russo et al.
CLINICAL THERAPEUTICS (2019)
2017 ESC/EACTS Guidelines for the management of valvular heart disease The Task Force for the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)
Helmut Baumgartner et al.
EUROPEAN HEART JOURNAL (2017)
Apixaban in Patients With Atrial Fibrillation After Transfemoral Aortic Valve Replacement
Julia Seeger et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2017)
Edoxaban for the Prevention of Thromboembolism in Patients With Atrial Fibrillation and Bioprosthetic Valves
Anthony P. Carnicelli et al.
CIRCULATION (2017)
Dabigatran Versus Warfarin After Bioprosthesis Valve Replacement for the Management of Atrial Fibrillation Postoperatively: DAWA Pilot Study
Andre Rodrigues Duraes et al.
DRUGS IN R&D (2016)
Dabigatran versus Warfarin in Patients with Mechanical Heart Valves
John W. Eikelboom et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Association of Warfarin Therapy Duration After Bioprosthetic Aortic Valve Replacement With Risk of Mortality, Thromboembolic Complications, and Bleeding
Charlotte Merie et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
Manesh R. Patel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Julian P. T. Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
Alessandro Liberati et al.
PLOS MEDICINE (2009)
Thromboembolic complications after surgical correction of mitral regurgitation - Incidence, predictors, and clinical implications
Antonio Russo et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Optimal INR for prevention of stroke and death in atrial fibrillation: a critical appraisal
A Oden et al.
THROMBOSIS RESEARCH (2006)
分享论文
